Fungi from the genus Acremonium have been reported from both terrestrial [1] [2] [3] and marine sources [4] [5] [6] and produce unique and biologically active secondary metabolites, the most well known being the antibiotic cephalosporin C. 7 Antioxidant hydroquinone derivatives 8 and a chlorinated polyketide 6 have been reported from an algal-derived Acremonium sp., while isolates derived from marine sponges have yielded alkaloids, 4,9 peptides, 10, 11 or oxygenated metabolites. 12 In 2005, Nasini et al. reported a series of 12 meroterpenoids, including acremines A
(1), F (2) , and N (3), from an endophytic strain of Acremonium byssoides isolated from sporangiospores of Plasmopara viticola in grapevine leaves. 1, 13, 14 Malik et al. described the isolation of a "norterpenoid" from the plant Periploca aphylla, 15 however the structure of this compound was later revised to that of acremine A (1) based on a synthetic study. 16 Acremine A has also been isolated from the fungus Myceliopthora lutea by Smetanina et al. along with isoacremine D and two spiroacremines. 17 Although the structure and 1 H NMR data of isoacremine D reported by the Russian group were identical to those of acremine D described by the Italian researchers, 1 the 13 C NMR and melting point data of the two samples differed.
South East Queensland. Colonies of Acremonium persicinum were successfully cultured by streaking small pieces of sterilized sponge sample onto malt extract and potato dextrose agar media made up in artificial seawater. Identification of the isolate was undertaken by performing colony PCR of the rDNA ITS followed by DNA sequencing. Following preliminary investigation of a small scale culture, large scale fermentation was carried out in malt extract media (4 L) made up in artificial sea water. After 4 weeks, the culture broth was extracted with EtOAc followed by n-BuOH to afford extracts from which six new acremine metabolites (4) (5) (6) (7) (8) (9) were isolated together with 9-O-methyl-acremine F (10), and spiroacremines A (11) and B (12) in addition to the known acremines A (1), F (2) , and N (3).
The 1 H and 13 C NMR data (Tables 1 and 2 ) for acremine A (1), the major component in the extract, are reported in CDCl 3 , while the 1 H NMR spectrum was also measured in acetone-d 6 for direct comparison with literature data. Nasini et al. determined the relative configuration of 1 by X-ray crystallographic analysis, while the absolute configuration was deduced as (4S, 6R) following Mosher esterification. 1 The specific rotation of 1 from A.
persicinum was measured as +13 compared to a literature value of + 22.3, consistent with a (4S, 6R) configuration. in acremine F), and was assigned as the C-1 epimer of acremine F (13). Table S1 in Supporting between the C-4 and C-6 hydroxy groups were thus favored. In cyclic organic compounds with a cis-1,3-arrangement of hydroxy groups, the diequatorial conformer is preferred in polar solvents but the diaxial conformer becomes an important contributor to the overall conformational equilibrium in non-polar solvents owing to the intramolecular hydrogen bonding between the two hydroxy groups. 19 In both 2a and 13a there is also the stabilizing feature of an equatorial Me group at C-6.
The relative and absolute configurational features of 2 were confirmed by an X-ray crystallographic study conducted on a derivative prepared from 9-O-methyl-acremine F (10).
For ether 10, a sodiated ion peak at m/z 265.1422 provided the molecular formula C 13 H 22 O 4 .
The 1 H NMR data were very similar to those of 2, except for a singlet at δ H 3.16 (3H) which gave HMBC correlations to the methyl groups at C-10 and C-11, as well as to C-9, and so revealed that a methoxy group had replaced the hydroxy group at C-9. On exposure to mildly acidic conditions during isolation, acremine F (2) may form a stable tertiary allylic carbocation at C-9, which then reacts with methanol to form 10. 20 The absolute configuration of 15 was determined by the anomalous dispersion method on a highly redundant data set collected with Cu-Kα radiation and confirmed a (1S, 4S, 6R) configuration spiro ring. 17 The carbonyl at δ C 192.6 was placed at C-1 based on an HMBC correlation to Me-12 (δ H 2.16), while the carbonyl group at δ C 189.1 was assigned to C-4 based on HMBC correlations to the methylene protons of C-7. In the side chain, a hydroxy group was placed at C-8 based on HMBC correlations from the methyl groups (δ H 1.27, 1.16) to C-8 (δ C 78.0). As in 4 and 5, the chlorine substituent was therefore placed at C-5. The relative configuration of the spiro centre followed from NOESY correlations between Me-11/H-8 and Me-11/H-7b which suggested that these protons were all on the same face. Similarly, H-2b and H-7a were on the same face based on the observed NOESY correlations between these two protons, but Candidate diastereomers 8a and 8d were modelled using Macromodel version 9.9 (New York) 23 and the structures further optimized with Gaussian version 09 (Wallingford), 24 resulting in 12 and 8 conformations within 3 kcal/mol of the global energy minimum for 8a
and 8d, respectively. The Boltzmann-weighted chemical shifts were calculated, but the values for 8a and 8d were similar and neither set could not be conclusively assigned to acremine Q. However the Boltzmann weighted proton NMR coupling constants calculated in vacuum using the method of Jain et al. 25 gave values that supported 8a as the preferred diasteromer. (see Table S3 absolute configuration of acremine Q was assigned (3R, 4R, 5S, 6R, 8R) as shown in 8.
Attempted reduction of acremine Q using Pd/C in EtOAc led to a mixture of products in insufficient quantity for individual identification.
Acremine R (9) was isolated as a colorless oil from RP-HPLC and had the same molecular formula C 12 The downfield chemical shift of C-9 suggested a chromane ring. 26 The signal at δ C 69.8 was Fraction 6 was subjected to NP-HPLC using RI detection, eluting with 25% EtOAc/hexanes, flow rate 2 mL/min over 40 min to obtain acremine O (6) (0.8 mg). Fraction 7 was purified through NP-HPLC using the same procedure as for fraction 6, and yielded acremine N (3) (2.1 mg). Fractions 8 and 9 (45 mg) were combined and subjected to NP-HPLC, employing 40% EtOAc/hexanes, flow rate 2 mL/min over 40 min to afford acremine N (3) (2.4 mg),
together with a mixture of acremine R (9) and spiroacremine A (11) (7.5 mg), then a fraction containing acremine P (7) (3.0 mg), and finally acremine Q (8) (1.7 mg) in order of elution.
The mixture of 9 and 11 was further purified by RP-HPLC using gradient elution from 60-80% MeOH/H 2 O (20 min), followed by isocratic 80% MeOH/H 2 O (10 min), flow rate 1.5 mL/min, and yielding spiroacremine A (11) (1.1 mg) and acremine R (9) (1.1 mg) in order of elution. The fraction containing acremine P (3.0 mg) was purified with NP HPLC using C NMR see Table 1 and Reduction of Acremine A with NaBH 4 . Acremine A (1) (7.0 mg) dissolved in EtOH (1 mL) was treated with NaBH 4 (1.3 mg, 1.1 equiv) at room temperature (rt). After 1 h, 1 mL acetone was added, followed by H 2 O (2 mL), and extraction with EtOAc (3 x 2mL). The organic layer was then collected, dried over MgSO 4 and concentrated under vacuo to obtain a mixture of acremine F (2) and 1-epi-acremine F (13) in a 2:1 ratio. The mixture (5 mg) was then subjected to RP-HPLC, UV 254 nm, using isocratic 15% MeCN/H 2 O (25 min), flow rate 1.5 mL/min to yield acremine F (2.0 mg) and 1-epi-acremine F (0.7 mg). 28 A complete sphere of data were collected and the absolute structure was determined by analysis of 1001 Bijvoet pairs using the method of Hooft et al. 29 implemented within PLATON. 30 The probability of the correct enantiomer (P2) was 1.000 using Student's t-statistics with a ν value of 10 and a Hooft parameter of -0.01 (6) . All 
